Marker Therapeutics (NasdaqCM:MRKR) FY Conference September 10, 2025 12:30 PM ET Speaker0Good afternoon, everyone, and welcome back to HC Wainwright's 27th Annual Global Investment Conference on September 8 to 10, 2025. My name is Patrick Truchio. I'm a Senior Healthcare Analyst at HC Wainwright. It's my pleasure to introduce our next company, Marker Therapeutics. Marker is focused on the development and commercialization of next-generation T-cell-based immunotherapies for patients with a wide range of bloo ...